In all hepadnaviruses, protein-primed reverse transcription of the pregenomic RNA (pgRNA) is initiated by binding of the viral polymerase, P protein, to the RNA element. Universally, consists of a lower stem and an upper stem, separated by a bulge, and an apical loop. Complex formation triggers pgRNA encapsidation and the -templated synthesis of a DNA oligonucleotide (priming) that serves to generate minus-strand DNA. In vitro systems for duck hepatitis B virus (DHBV) yielded important insights into the priming mechanism, yet their relevance in infection is largely unexplored. Moreover, additional functions encoded in the DHBV (D) sequence could affect in vivo fitness. We therefore assessed the in vivo performances of five recombinant DHBVs bearing multiple mutations in the upper D stem. Three variants with only modestly reduced in vitro replication competence established chronic infection in ducks. From one variant but not another, three adapted new variants emerged upon passaging, as demonstrated by increased relative fitness in coinfections with wild-type DHBV. All three showed enhanced priming and replication competence in vitro, and in one, DHBV e antigen (DHBeAg) production was restored. Pronounced impacts on other D functions were not detected; however, gradual, synergistic contributions to overall performance are suggested by the fact of none of the variants reaching the in vivo fitness of wild-type virus. These data shed more light on the P-D interaction, define important criteria for the design of future in vivo evolution experiments, and suggest that the upper D stem sequences provided an evolutionary playground for DHBV to optimize in vivo fitness.
Hepadnaviruses are small enveloped hepatotropic DNA viruses that replicate through protein-primed reverse transcription (for reviews, see references 8 and 38) . Human hepatitis B virus (HBV) and duck HBV (DHBV) are the respective prototypes of the mammalian and avian HBVs, which share a similar genome organization and replication strategy (Fig. 1A) . Their ϳ3-kb genomes encode a single core protein, three or two (avian viruses) envelope proteins, an unusual reverse transcriptase (P protein), and, only in the mammalian viruses, the poorly understood X protein. Virions contain the genome as a relaxed circular DNA (rcDNA), which upon infection is converted into nuclear covalently closed circular DNA (cccDNA), the template for all viral transcripts. In addition to the subgenomic RNAs (sgRNAs), two types of greater-than-genomelength RNAs are produced. The precore RNAs serve for translation of the precursors of the secretory hepatitis B virus e antigens (HBeAg and DHBeAg, respectively), which may modulate the host's immune response but are nonessential. The pregenomic RNAs (pgRNAs), by contrast, are vital as mRNAs for core and P protein and by constituting the obligate template for new DNA genomes.
Reverse transcription begins with specific packaging of pgRNA into newly forming capsids, triggered by binding of P protein to the 5Ј-proximal ε (Dε for DHBV) stem-loop (Fig.  1A) ; in avian HBVs, this requires an additional, far-downstream cis element ("region II" (11, 44) ). The second crucial function mediated by the P-ε interaction is replication initiation itself (priming). A Tyr residue in the terminal protein (TP) domain of P protein provides the covalent acceptor site for the 5Ј terminal nucleotide of a short DNA oligonucleotide that is templated by a bulged region within ε; remaining linked to TP, it serves to initiate full-length minus-strand DNA [(Ϫ)DNA] synthesis from a complementary site at the 3Ј-proximal direct repeat DR1* (Fig. 1A .) The pgRNA is concomitantly degraded except for the very 5Ј residues (22) , which, after translocation to DR2, act as RNA primer for plus-strand DNA [(ϩ)DNA] synthesis, eventually yielding new rcDNA. As a by-product, some double-stranded linear DNA (dsL-DNA) is formed when the RNA primer fails to translocate ("in situ priming").
For lack of direct structural data, the molecular interactions governing the P-ε interaction are still not well understood. The overall structure of ε ( Fig. 2A) , with a lower stem and an upper stem, separated by a bulge, and an apical loop (5, 19, 30) , is conserved in all hepadnaviruses, suggesting it is functionally important.
Mutational studies in transfected cells support this view for both HBV (30, 40) and DHBV (9, 27) . More mechanistic insights came from in vitro-reconstituted priming-active DHBV P-ε initiation complexes generated in rabbit reticulocyte lysate (7, 9, 55, 61, 62) or more recently from purified components (6, 24, 52, 53) . For instance, Dε variants lacking the loop or the bulge and some point mutations, e.g., at posi-tion 4 in the apical loop ("L4"), fail to bind P protein, and others, even if bound, are not used as a template. This deficiency correlates with an inability to undergo a major conformational change in the upper stem region that typically occurs with priming-competent Dε RNAs (7) . Hence, priming occurs in at least two steps (Fig. 1B) , in which a functional Dε RNA must present itself to P protein in a recognizable form for initial binding and then be able to adopt a new conformation in the active priming complex. However, in vitro priming activity does not per se indicate that the authentic primer, matching the DR1* acceptor site and thus crucial for proper minus-strand DNA synthesis, has been made. Even less is known about the HBV P-ε interaction, because in vitro only binding but no priming activity has yet been achieved (23) .
Both physical and subsequent productive P binding must rely on protein-RNA interactions involving specific nucleobases and/or structural features of the RNA backbone. Owing to the sequence dependence of RNA structure, a clear distinction is often impossible. To overcome this and other restrictions of single-site mutations, we had previously used an in vitro SELEX (systematic evolution of ligands by exponential enrichment) procedure to select P protein binding individuals from a pool of RNAs in which 8 positions in the upper stem, excluding the strictly conserved loop sequence, had been randomized (25) . Rather than toward the wt Dε sequence, the pool converged into a collection of RNAs in which the common feature was the absence of base pairing in the top part of the upper stem, brought about by the accumulation of C residues in both half-stems. All selected RNAs bound tightly to P protein, and yet, expectedly, some supported in vitro priming while others did not. Variants Dε/S1 and Dε/S2 appeared to be of particular interest for the current study, differing heavily from wt Dε in sequence and structure ( Fig. 2A ). Both contain a fortuitous U2591g mutation in the conserved loop sequence (lowercase letter denotes a difference from the wt sequence); the loop in Dε/S2 lacks, in addition, nucleotide G2589. Dε/S1 RNA was in vitro priming competent, whereas Dε/S2 RNA was not. The other two sequences are Dε/S5 and Dε/S12, identical to each other except at position 2586 (Fig. 2A) ; Dε/S5 had shown weak and Dε/S12 strong in vitro priming activity despite similar affinities to DHBV P (25) .
Together, the in vitro data demonstrated that various RNAs with open upper stems can productively interact with DHBV P protein in vitro. Similar structures are also found in the Hε signal of heron HBV (HHBV) ( Fig. 2A) and some other avihepadnaviruses, including "Eastern" isolates of DHBV; however, in all Western isolates a nearly completely based paired upper stem is strictly conserved (see Fig. S1 in the supplemental material for an alignment). This conservation may reflect optimization for interaction with the specific P protein yet also the presence of multiple additional functions overlappingly encoded in the Dε sequence (Fig. 2B) . These include the positive effector of transcription (pet) element, whose absence essentially abolishes pgRNA transcription (26) ; the acceptor site for the proposed DHBV element (54) , which in HBV is important for (Ϫ)DNA synthesis (1, 54) ; the major splice donor (GT2614/15) for a spliced form of pgRNA (42) ; and the preC open reading frame (ORF) required for DHBeAg synthesis. Partial overlaps exist with other cis elements, including region A, involved in splicing regulation by base pairing with downstream region B (34), and region 3E, proposed to facilitate proper (ϩ)DNA synthesis and rcDNA formation by base pairing, on minus-strand DNA, with region M3 (33) . Immediately neighboring Dε are the translational start of the core protein and a small hairpin-forming sequence that promotes proper (ϩ)DNA formation (21) . Impairment of any of these functions by mutations in the Dε sequence may reduce if not Select cis elements are indicated; ε, RNA stem-loop; εII, region II, corequired for pgRNA packaging; DR, direct repeat; 3E, 5E, M3, and M5, elements on minus-strand DNA proposed to promote rcDNA formation by base pairing (33) ; white arrow, heterologous promoter controlling pgRNA transcription; gray arrow with dashed outline, endogenous core promoter controlling pgRNA and precore RNA transcription on authentic cccDNA. Numbers are nucleotide positions. The terminally redundant pgRNA serves as mRNA for core and P protein. The boxed ATG marks the start of the core ORF. Binding of P protein to the 5Ј Dε stem-loop initiates pgRNA encapsidation and synthesis of a Dε-templated DNA oligonucleotide that serves to initiate full-length minus-strand DNA from DR1*. Further reactions leading to rcDNA are not shown. (B) Stepwise priming model derived from in vitro data. Upon activation by chaperones, P adopts a metastable Dε RNA binding-competent state. Formation of a priming-active P-Dε complex is accompanied by structural rearrangements in the RNA (7) and the protein (52, 55) . RNAs unable to undergo the rearrangement may bind to P but fail to be used as template. The information for proper initiation site selection must reside in the structure of the active complex.
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IN VIVO ANALYSIS OF DHBV ENCAPSIDATION SIGNAL VARIANTS 9301 abolish a mutant virus' ability to spread in vivo without being detectable in in vitro priming experiments. Unlike the case with HBV, infectivity of variant DHBV genomes can be assessed in vivo in the natural host, providing an ultimate functional test for all aspects of the Dε sequence. The first goal of this study was therefore to elucidate whether viruses containing severely altered upper stem sequences were viable in vivo and how their fitness would compare with that of wt DHBV, and to correlate potential fitness differences with the mutational impact on specific functions of the Dε sequence. Second, we anticipated that, should some variants form viable viruses, their passaging in ducks might lead to adaptive mutations that could add to an understanding of the natural conservation versus variability of the Dε sequence, as well the evolutionary capacity of hepadnaviruses in general, an important issue for development of drug resistance and vaccine escape in HBV. Similar in vivo evolution experiments, mostly with bacteriophages or eukaryotic viruses that can be propagated in cell culture, have recently provided surprising new insights into virus evolution (14, 15, 43, 49) .
MATERIALS AND METHODS
Cells. LMH cells were cultured and transfected as previously described (13) , except that TransIT-LT1 (Mirus) was used as a transfection reagent. Cells were usually harvested 3 or 4 days posttransfection. Primary duck hepatocytes were obtained and cultured as described previously (13) .
Plasmid constructs. The parental vector pCD16 contains a 1.1ϫ DHBV16 genome (GenBank accession no. K01834) under the control of the cytomegalovirus (CMV) immediate-early (IE) enhancer promoter (42) . pCD16 vectors carrying mutant 5Ј plus 3Ј Dε sequences were obtained from the corresponding vectors still carrying a 3Ј wt Dε (25) by standard procedures. In vitro transcription vectors for mutant Dε transcripts were generated by cloning PCR products, containing a 5Ј-terminal T7 RNA polymerase promoter sequence encompassed in the forward primer and obtained from the corresponding pCD16 vectors as templates, into pUC19; the T7 promoter containing the pUC plasmid is referred to as pUC19T7. All constructs were verified by sequencing.
Recombinant virus production. Recombinant viruses were obtained from transfected LMH cells as previously described (13) . In brief, cell culture supernatants from days 3 and 4, 5 and 6, and 7 and 8 posttransfection (p.t.) were collected and pooled (supernatants from days 1 and 2 were discarded). After cellular debris was removed by low-speed centrifugation, viral particles were concentrated by precipitation with 30% PEG-8000-1.5 M NaCl and resuspension of the pellets in 1/50 the original volume of phosphate-buffered saline (PBS) containing 10% glycerol. Viral titers were determined by quantitative PCR (qPCR) after digestion of nonenveloped nucleic acids with pronase and DNase I as described previously (13) .
In vitro infections. Primary duck hepatocytes (PDH) were inoculated at a nominal multiplicity of infection (MOI) of 100, assuming one viral genome equivalent (vge) equals one infectious particle (29), with recombinant virus or viremic duck serum as previously described (13) . For analysis of intracellular viral DNAs, including cccDNA, total DNA was prepared by SDS lysis; viral DNA in enveloped particles was enriched by pronase-plus-nuclease treatment and used for Southern blotting as described previously (13) .
In vivo infections. Two-to three-day-old Pekin ducklings from a commercial supplier were injected into the foot vein with transfection-derived virus or viremic duck serum of known vge content. For monitoring viral spread, blood was collected weekly and viral load was determined by qPCR; PreS antigenemia was monitored by Western blotting. All procedures were essentially conducted as described in reference (13) . Animal experiments were approved by the local authorities (Regierungspräsidium Freiburg, project G02/36) and performed in compliance with German animal welfare legislation at a registered facility of the University Hospital Freiburg under veterinary supervision.
Detection of viral nucleic acids by hybridization techniques. Replicative DNA intermediates in transfected LMH cells were isolated from cytoplasmic nucleocapsids and analyzed by Southern blotting, using 32 P-labeled DHBV DNA probes, as previously described (13) . For detection of DNA in enveloped particles by Southern blotting or qPCR, nucleic acids not protected by an envelope were digested with DNase plus pronase as described previously (13) . For simultaneous detection of cccDNA in PDH, total cell lysates were prepared by SDS lysis (13) . For quantitation, signal intensities were determined by phosphorimaging and evaluated using the AIDA (Raytest) or ImageQuant (GE Healthcare) software program. To compare the relative performances of individual constructs, signal intensities generated by the mutants were normalized to those generated by the wt construct in the same experiment; experiments were repeated at least twice and up to six times as needed. Mean values Ϯ standard deviation (SD) are given as calculated using the GraphPad Prism 5 software program. Native agarose gel electrophoresis (NAGE) for direct detection of encapsidated DNA was performed as described previously (59) ; equally sized aliquots from cytoplasmic lysates run in parallel served for immunological detection of capsids, using monoclonal antibody (MAb) 2B9-4F8 (59). For Northern blotting, nucleocapsid-associated RNAs and total cytoplasmic RNA were obtained using RNeasy kits (Qiagen) as described previously (31); polyadenylated RNAs were enriched from total RNA preparations using the Oligotex Direct mRNA kit (Qiagen). DHBV specific RNAs were detected using the same 32 P-labeled DHBV probe used for Southern blotting. PCR. qPCR was performed in a LightCycler 1.5 instrument (Roche), using FastStart Taq polymerase and SYBR green as described previously (13) . Total DHBV DNA contents were determined using the primers D1389ϩ (TGGATT TCTCTCAGTTCTCCAAAGG) and D1496-(TCCTGGGCATCCCCACGG FIG. 2 . Structures of ε RNAs and proposed functions of the Dε sequence. (A) Secondary structures of HBV ε and Dε and of the artificial Dε variants investigated. For ε and Dε, the base pairings shown were confirmed by nuclear magnetic resonance (NMR), including the presence of stable apical loops (17, 19) ; the initially assumed, nonstructured loop sequences are underlaid in gray. The 3Ј-proximal part of the bulge serves as a template for the DNA primer (boxed sequences linked to Tyr). For Dε, the precore and core start codons and the major splice donor (SD) site are indicated. Nucleotides differing from wt Dε in the upper stems of the Dε variants are denoted by lowercase lettering. The structure of HHBV ε (Hε) is consistent with NMR data (19) ; structures of the artificial Dε variants have not yet been confirmed. Note the fortuitous U2591g mutation in Dε/S1 and Dε/S2, which, in addition, lacks G2589. (B) Known and proposed functions overlapping and/or neighboring the Dε stem-loop sequence. Coordinates are derived from the corresponding references cited in the text. GC), targeting a region that is conserved in all avihepadnaviruses, or primers targeting sequences upstream and downstream of Dε, i.e., DR1-SpeI DHBVϩ (aaaaaaactagTACACCCCTCTCCTTCGGAGC; the nonspecific 5Ј sequence in lowercase letters creates a SpeI restriction site for cloning purposes) and D2738-(TTAGCATCTCTAACAAGATCATC). Cycling conditions were 40 cycles of 5 s at 95°C, 10 s at 55°C, and 15 s at 72°C. Viruses containing non-wt Dε sequences were discriminated using D2738Ϫ as a common reverse primer and forward primers specific for the individual Dε sequence, i.e., DHBV/Hε-SpeI-2570ϩ (TCTTTAACTAGTCCTCGCTGTTGTTCC), S1-SpeI-2582ϩ (aactagtGAAC GCTGTGGTCCAC), and S5/S12-SpeI-2570ϩ (TCTTTAACTAGTCCCCACT GTTGTCCAC). Cycling conditions were 40 cycles of 5 s at 95°C, 10 s at 60°C, and 24 s at 72°C. Each qPCR run included plasmid DNA standards to generate a calibration curve and a water negative control. In addition, specificity of amplification was controlled by melting-curve analysis; specific products were defined as having the same peak melting temperature as the PCR product amplified from a plasmid encoding the same sequence. Based on plasmid templates, under the conditions used, all Dε-specific primers displayed an at least 10 5 -fold discrimination against the wt Dε sequence. For preparative PCR, including for direct sequencing and cloning, the primers DR1-SpeI DHBVϩ and D2738Ϫ were routinely used. To amplify an about 2.0-kb fragment, DR1-SpeI DHBVϩ was combined with D1714Ϫ (GAAGTCATCCATATAAGT); for fullgenome PCR, the primers DHBV-FL-Salϩ (aaaaaagtcgacCTTAAGAATTAC ACCCCTCTCCTTCGGAGC; SalI cloning site underlined) and DHBV-FLSpeϪ (ttttttactagtAAGTTCCACATAGCCTATGTGGAATATATAT; SpeI site underlined) were used. For direct sequencing of the Dε regions, the short PCR products were sequenced using D2738Ϫ; about 1.3 kb of sequence outside Dε was obtained from the 2-kb PCR products using D722ϩ (GATATCTAgAC ATTTGGTCAC) as a sequencing primer. Full genome sequences were obtained from cloned (via SalI and SpeI) full-length PCR products by primer walking.
In vitro priming. In vitro priming assays were performed as described previously (25) using DHBV P protein in vitro translated in rabbit reticulocyte lysate and in vitro-transcribed Dε RNAs obtained from the corresponding pUC19T7 plasmids, linearized immediately downstream of Dε, using the MEGAscript kit (Ambion). RNA concentrations were determined photometrically and by comparison with a tRNA standard on ethidium bromide-stained agarose gels; all RNAs were used at a 1 M final concentration. Priming was initiated by adding [␣- 32 P]dATP and unlabeled dGTP and dTTP. Labeled P protein was detected by SDS-PAGE followed by autoradiography or phosphorimaging. Relative signal intensities were estimated by quantifying the band intensities using the ImageQuant (GE Healthcare) software program.
DHBeAg detection. Serum DHBeAg was detected by immunoprecipitation followed by Western blotting. For immunoprecipitation, 1 ml (each) of viruspositive (with titers of Ն10 8 vge/ml) or virus-negative (negative-control) duck serum was incubated overnight at 4°C with 50 l (bed volume) of protein A Sepharose beads loaded with polyclonal rabbit antibodies raised against recombinant DHBV core protein (no. 11-99) (59) . Then, the beads were washed 10 times with PBS, and bound antigen was released by boiling in SDS sample buffer. Equal aliquots of the SDS lysates were separated by SDS-PAGE and blotted to a polyvinylidene difluoride (PVDF) membrane, and DHBeAg was detected using the alkaline-phosphatase (AP)-conjugated MAb 2B9-4F8, which recognizies a linear epitope present on DHBV core protein and DHBeAg (59) , and a chemiluminescent substrate.
RESULTS

Basic replication competence in transfected LMH cells of DHBV genomes with altered D sequences.
Replication competence of the different Dε sequences in the context of a complete viral genome was first addressed in LMH cells transfected with CMV promoter-driven constructs, based on the wt DHBV16 vector pCD16 (42) . To exclude fortuitous formation of wt DHBV genomes via homologous recombination in the transfected cells, both copies of the authentic Dε sequence (Fig. 1A) were replaced by the variant sequences Dε/S1, Dε/S2, Dε/S5, Dε/S12, and Hε ( Fig. 2A) . The respective virus genomes were termed DHBV/S1, DHBV/S2, DHBV/S5, DHBV/S12, and DHBV/Hε. Four days posttransfection, viral DNAs from cytoplasmic nucleocapsids were analyzed for replicative intermediates by Southern blotting. In line with in vitro priming results (25) , variant DHBV/S2 showed no replication and DHBV/S5 only weak replication compared to that of wt DHBV; signals for DHBV/S1, DHBVS12, and DHBV/Hε were much less reduced (1.3-to 2-fold). The mean values Ϯ standard deviations (SD) for the sum of rcDNA plus doublestranded DNA (dsDNA) signals from 6 independent transfections, normalized to those for wt DHBV, are shown at the bottom of Fig. 3A . Analysis of capsid-associated DNA by native agarose gel electrophoresis (NAGE) confirmed a complete lack of signal for DHBV/S2 (Fig. 3B, top) . Surprisingly, this construct generated around 5-fold more capsids than the others (Fig. 3B, bottom) . This was not due to enhanced pgRNA accumulation; to the contrary, Northern blotting of
FIG. 3. Effects of Dε mutations on DHBV replication in transfected LMH cells. (A)
Replicative DNA intermediates. DNA from cytoplasmic nucleocapsids was analyzed by Southern blotting. rc, relaxed circular DNA; dsL, double-stranded linear DNA. The mean relative replication levels (sum of rcDNA plus dsL-DNA signals) as percentages of that of the wt DHBV16 control Ϯ SD (n ϭ 6) are given at the bottom. (B) Native agarose gel electrophoresis. Equal aliquots of cytoplasmic lysates were separated by NAGE; after blotting, viral DNAs were detected by using a 32 P-labeled DHBV probe, and DHBV capsids were detected by using monoclonal anti-DHBV core protein antibody MAb 2B9-4F8 (59) . Note the complete lack of DNA signal for DHBV/S2 and the simultaneous presence of increased amounts of capsids. (C) Northern blot of total cytoplasmic DHBV RNA. RNAs from equal aliquots of cytoplasmic lysates were resolved by Northern blotting. DHBV RNAs were detected using the same probe as in panels A and B. (D) Northern blot of capsid-associated DHBV RNA. Cytoplasmic lysates were treated with micrococcal nuclease prior to Northern blotting. The doublet signals (lower band denoted by an asterisk) may originate from partial degradation of the 3Ј-terminal pgRNA region (45) . The lack of signal for DHBV/S2, despite generation of large amounts of capsids, indicates a massive pgRNA encapsidation defect.
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total cytoplasmic RNAs ( Fig. 3C ) revealed smaller amounts of pgRNA for DHBV/S2 (23.5% Ϯ 4.4% compared to that for wt DHBV; n ϭ 3) than for the other variants (50% or more compared to wt DHBV). These last variants showed somewhat reduced levels of capsid-associated pgRNA ( Fig. 3D ), whereas no signal at all was detectable for DHBV/S2, indicating a massive pgRNA packaging defect. Hence, the Dε/S2 mutations prevent a productive interaction with P protein.
The amounts of viral DNA in extracellular particles were largely proportional to those in intracellular nucleocapsids produced by each variant, as shown by Southern blotting (see Fig. S2 in the supplemental material, which includes additional variants described below). This was corroborated using a modified protocol aimed at producing larger amounts of virions for subsequent infection experiments. Here, the culture supernatants were collected for a total of 10 days. Particles concentrated from the pooled supernatants were treated with pronase plus DNase to digest DNA not protected by the viral envelope (plasmid DNA and DNA in nonenveloped nucleocapsids). The protected viral DNA amounts were determined by qPCR (13) . Typically, around 10 9 viral genome equivalents (vge) per ml were found for wt DHBV, (3 to 5) ϫ 10 8 vge/ml for variants DHBV/Hε, DHBV/S1, and DHBV/S12, and 1 ϫ 10 8 vge/ml for DHBV/S5. Very low qPCR signals (Ͻ5 ϫ 10 6 vge/ml) were also seen in medium from DHBV/S2-transfected cells; hence, DHBV/S2 may not be entirely replication defective, or a small fraction of the input plasmid DNA survived the treatment. Conversely, the clear-cut differences between individual samples underline the specificity of the protocol used.
Replication-competent DHBVs with mutant D sequences are infectious for primary duck hepatocytes. As an initial infectivity test, transfection-derived DHBV/S1, DHBV/S5, DHBV/S12, DHBV/Hε, and wt DHBV virions were used to inoculate primary duck hepatocytes (PDH); this system differs from transfection in its dependence on virus-mediated cell entry and on cccDNA rather than plasmid DNA as a transcription template. Seven days postinoculation (p.i.) at a nominal multiplicity of infection (MOI) of 100, assuming each vge corresponded to an infectious particle (29) , total intracellular viral DNA was analyzed by Southern blotting (see Fig. S3 in the supplemental material). All variants showed, besides rcDNA and dsL-DNA, a new band migrating at the position expected for cccDNA (close to the 1.8-kb dsDNA marker). Compared to results for wt DHBV, the sum of all signals per lane was reduced about 2-fold for variants DHBV/S1, DHBV/S12, and DHBV/Hε and at least 5-fold for DHBV/S5. Stronger reductions were seen for the cccDNA signals only (2.5-to 3-fold for the first group of variants and about 15-fold for DHBV/S5); these values may be more representative because a contribution by the inocula to the cccDNA signals can be excluded. In sum, all variant viruses that replicated in LMH cells also formed infectious virions. Overall, the replication levels upon infection resembled those seen upon transfection.
DHBVs with variant D sequences can establish chronic infection in vivo. PDH cultures lack major factors that could affect in vivo viability of a virus, including an intact immune system. While such effects may be minimized by inoculating freshly hatched birds (28) , innate (57) and maturing adaptive (65) immune responses may limit the spread of a virus variant to the extent that no overt infection markers are detectable. Conversely, infectibility of PDH ceases within days, whereas in vivo infection typically goes on until the entire liver is infected (29, 64) . Assuming an average number of 10 10 hepatocytes per liver (28) , this implies, depending on the inoculum size, amplification of the input virus by several orders of magnitude, with a concomitantly increased chance to accumulate mutations.
In a first set of experiments, we inoculated 10 8 vge transfection-derived DHBV/S1, DHBV/S5, DHBV/S12, DHBV/Hε, and wt DHBV virions into 2-day-old ducklings. To account for variations in genetic and immunological status, three ducks per construct were used; all animals were pretested for PreS/S antigenemia beforehand (13) , and those scoring positive were excluded.
Serum samples were obtained at weeks 1, 2, 3, and 4 p.i., and the ducks were finally bled on day 42. Sera were analyzed for PreS/S antigenemia by the immuno-dot blot method and for virion DNA by qPCR (Fig. 4) . Two of three wt-DHBV-inoculated ducks (no. 12/16 and 12/17) developed quickly detectable antigenemia and high-titer viremia (10 8 to 10 9 vge/ml); in one duck (no. 12/15), infection was delayed. Similar patterns have previously been observed (13) . None of the animals in- oculated with DHBV/S5 (which had shown around 5-foldreduced replication in LMH cells) developed detectable infection markers. All other variants established infection in one (DHBV/S1) or more (DHBV/S12 and DHBV/Hε) animals. DHBV/Hε showed a modestly delayed spread compared to wt DHBV in two of three ducks (no. 12/12 and 12/14), whereas DHBV/S1 and DHBV/S12 spread more slowly and/or reached lower maximal viremia titers.
To test for potential wt DHBV contamination and/or adaptive mutations, PCR products spanning about 170 bp, including the Dε region (nucleotide [nt] positions 2570 to 2738) derived from the virus-positive final sera of the DHBV/Hε-inoculated (no. 12/12 to 12/14) and DHBV/S1-inoculated (no. 12/1) animals were directly sequenced, without revealing any dominant alteration (not shown); we estimate that a specific mutation present at a frequency of 10% or more in the population would have been detected. Hence, upon inoculation with a number of virions nominally sufficient for initial infection of about 1% of hepatocytes, no emergence of dominant new variants was detectable. These data established that the artificial viruses were functional in vivo; hence, their Dε mutations did not abolish any function that is essential for replication and infectivity.
DHBV/H did not accumulate dominant new mutations during in vivo passaging. Serial passaging should maximize the chances for accumulation of potentially beneficial mutations and their fixation. For such passaging experiments, we chose DHBV/Hε as a variant with nearly wt-DHBV-like infection characteristics and DHBV/S1 as a variant exerting reduced spreading kinetics and/or maximum titer.
Three of three ducks inoculated with 10 8 vge of serumderived DHBV/Hε (from animal no. 12/12; see Fig. 4 ) developed early-onset (day 7 p.i.) PreS/S antigenemia and high-level (10 8 to 10 9 vge/ml) viremia (animals 25/17 to 25/19; Fig. 5A ). Titers of 10 8 to 10 9 vge/ml persisted throughout the experiment in the absence of detectable wt-DHBV contamination, demonstrating DHBV/Hε was principally able to establish persistent infection with wt-DHBV-like kinetics. The faster onset compared to inoculation with transfection-derived virions could have resulted from adaptive mutations. However, direct sequencing of the Dε region derived from viruses in the end sera of animals no. 25/17 and 25/18 detected no dominant alterations except for a G2562T mutation immediately upstream of the ε stem-loop, which restored the original DHBV sequence; as found retrospectively, however, this mutation was already present in the corresponding plasmid vector. Sequencing of individual clones derived from the PCR products revealed single nucleotide exchanges in 3 of 10 clones but none to the same new nucleotide at the same position (see Fig. S4 in the supplemental material). Hence, the DHBV/Hε sequence remained largely stable over two in vivo passages; the potential presence of mutations elsewhere was not addressed at this stage. The faster infection kinetics may thus relate to an increased infectivity of the virions produced in the natural host over that of those derived from transfected chicken cells or to a higher susceptibility of the specific batch of ducks.
DHBV/H was outcompeted in mixed infections with wt DHBV. The infection characteristics seen above suggested an only minor impact of the mutations in DHBV/Hε on viral fitness. However, a more stringent test is to assess relative fitness, i.e., the ability of a mutant virus to compete with wt virus, which can be assumed to be optimally adapted to its natural host (43) . Accordingly, we assessed how well DHBV/Hε performed in mixed infections with wt DHBV (Fig.  5B) , an approach pioneered for DHBV by Summers and coworkers (32, 63, 64) .
Four ducklings each were inoculated with transfection-derived virions; DHBV/Hε was kept constant at 10 7 vge/duck and admixed with 10 4 (ratio 1,000:1), 10 5 (1,000:10), or 10 6 (1,000: 100) vge of wt DHBV (ducks 25/1 to 25/12). Sera were monitored over 6 weeks for PreS/S antigenemia and by qPCR for viremia; variant versus wt-specific primers served to distinguish the two virus types by qPCR. All but one duckling (no. 25/2) developed high-titer wt DHBV viremia (up to Ͼ10 10 vge/ml). DHBV/Hε was found in one animal (no. 25/1) from the 1,000:1 group and in three animals (no. 25/5 to 25/7) from the 1,000:10 group, but at 3-to 4-log-lower titers than for wt DHBV. In the 1,000:100 group, DHBV/Hε was not detectable at any time point. Hence, although DHBV/Hε was able to establish wt- DHBV-like infections on its own, in vivo amplification of wt DHBV was orders of magnitude more efficient in direct competition. DHBV/S1 slowly evolved into a restricted set of new variants with increased fitness. DHBV/S1 possessed the most divergent Dε sequence, including the T2591g mutation in the conserved loop sequence (loop position 5), yet was infectious in vivo (Fig.  4) . Two ducklings were each inoculated with 10 5 vge serumderived virus from duck no. 12/1, one with 10 8 vge (no. 13/43). Only this animal developed viremia, which dropped from 10 9 vge/ml at week 2 p.i. to about 2 ϫ 10 7 vge/ml at week 7 p.i., where it remained until the end of the experiment at week 24 p.i. (not shown). Direct sequencing revealed some heterogeneity in the Dε region (see Fig. S6 , top panel, in the supplemental material), yet the background noise in the chromatograms obscured more-detailed conclusions. Therefore, the Dε region was amplified from the week-24 p.i. serum and cloned. Of 10 clones, none contained the original Dε/S1 sequence; instead, three specific variations were found (see Fig. S5A in the supplemental material), namely, G2591A (5 of 10), G2591T (1 of 10), and the double mutation A2584T plus A2620G (3 of 10), which always cooccurred; one clone contained a single T2604C mutation, which was not, however, seen again in subsequent experiments (see below). The mutations at position 2591 both replace the fortuitous G residue at the loop 5 position (L5G) of DHBV/S1, either to T as in wt DHBV or to A ( Fig. 2A ; see also Fig. S5B in the supplemental material); we will refer to these new variants as DHBV/S1-L5T and DHBV/S1-L5A. For the double mutant, termed DHBV/S1-V2, A2584T (slightly upstream of the apical loop) also represents a reversion to the wild-type (wt) sequence; A2620G is located just downstream of the Dε stem-loop. None of the four mutations was detectable by direct sequencing in the transfection-derived DHBV/S1 virus stock ( Fig. 6 ; see also Fig. S5C , top panels, in the supplemental material), nor in the serum of the initially infected duck no. 12/1.
To assess whether the S1-L5T, S1-L5A, and S1-V2 mutations occurred by chance, we inoculated four more ducklings with a fresh stock of transfection-derived DHBV/S1; two animals received 10 6 vge (no. 20/23 and 20/24), and two received only 10 4 vge (no. 20/25 and 20/26). All ducks except no. 20/26 developed infection markers. Sequencing of the Dε region from sera obtained 6 weeks p.i. showed, for the higher-doseinoculated animals, the original DHBV/S1 sequence; however, in duck no. 20/25, the same nucleotide mixtures at the same positions as in the above-described experiment were seen (Fig.  6, bottom panel) , supporting a biological benefit of these mutations.
To see whether additional or other mutations would be selected upon further passaging, serum from duck no. 13/43, containing a mixture of the three new DHBV/S1 variants (see above), was inoculated at 10 7 vge into three fresh ducklings (no. 17/2, 17/5, and 17/7). All had developed viremia by day 26 p.i., and serum from the highest-titer animal (no. 17/7, with 5 ϫ 10 8 vge/ml) was used to inoculate three more ducklings (no. 18/1, 18/2, and 18/3) with 10 7 vge each. All three animals had developed viremia by day 19 p.i.; direct sequencing of the Dε regions in sera from ducks no. 13/43, 17/7, and 18/2 (see Fig. S6 in the supplemental material) revealed the increasing emergence of the same mutations at positions 2584, 2591, and 2620 as before (see above). Consistently, of 10 clones derived from serum of duck 18/2, only one corresponded to the original DHBV/S1 sequence; the other 9 contained exactly the same previously found mutations.
To address potential mutations outside Dε, we obtained direct sequences of full-length-genome PCR products from serum from duck 18/2. No accumulation of specific mutations comparable to those at positions 2584, 2591, and 2620 was seen anywhere else; this was confirmed by the absence of mutations outside the Dε region in two fully sequenced cloned genomes. Thus, additional mutations, if any, can be present only at a much lower frequency. Similarly, no deviation from the original DHBV16 sequence was seen over about 1.3 kb of length in a 2-kb PCR product encompassing Dε and region II, derived from duck no. 12/17, which had developed high-titer infection upon inoculation with transfection-derived wt DHBV (Fig. 4) .
Together, these data confirmed a selective pressure toward altering the artificial Dε/S1 sequence or its immediate vicinity (position 2620) while keeping the rest of the genome unchanged.
Evidence for adaption: passaging-derived new DHBV/S1 variants outperform their DHBV/S1 parent in vivo. As a reference for subsequent in vivo competition experiments involving the new DHBV/S1 variants, we first compared the relative fitness of the original DHBV/S1 virus to that of wt DHBV. Three ducks each were inoculated with 10 7 vge of DHBV/S1 to To minimize the potential presence in the inoculum of new DHBV/S1 variants, transfection-derived virions were used. Two animals from each group became viremic, but exclusively with wt DHBV; notably, in the 1,000:1 group, viremia was transient and very low titer (Fig. 7A) , and it displayed delayed kinetics in the 1,000:10 group, though both animals eventually developed high-titer infection. The reasons are unclear but may relate to a vaccination-like effect caused by the excess slowly spreading DHBV/S1 virus.
Next, we performed analogous coinfection experiments with the new DHBV/S1 variants DHBV/S1-L5A, DHBV/ S1L-5T, and DHBV/S1-V2 (Fig. 7B) ; to prevent contributions from potentially unnoticed mutations elsewhere, the specific mutations were introduced by cloning into the pCD16 plasmid backbone, and transfection-derived virions at 10 7 vge were used for coinoculation of three ducklings each with wt DHBV at 10 4 vge. In the virus-positive animals coinoculated with DHBV/S1-L5A (no. 22/1 and 22/3) and DHBV/S1-L5T (no. 22/5), wt DHBV was the dominant virus, yet the variants persisted at 2-log-lower (S1-L5T) and 2-to 3-log-lower (S1-L5A) titers until day 42 p.i. Two of the DHBV/S1-V2-coinoculated ducks (no. 22/8 and 22/9) showed viremia (ϳ10 7 vge/ml) exclusively with the variant. Hence, all three new S1 variants performed better in direct competition with wt virus than the original DHBV/S1; in particular, DHBV/S1-V2 was able to outcompete wt DHBV when given at 1,000-fold excess.
To confirm this ranking, we coinoculated groups of three ducks each with 10 7 vge of the original DHBV/S1 virus and 10-fold less of each of its descendants. Direct sequencing of FIG. 7 . Evidence for increased fitness of the newly emerged DHBV/S1 variants over that of their ancestor. (A) The parental DHBV/S1 virus inoculated at 1,000-fold excess cannot compete with wt DHBV. The indicated ducks were inoculated with 10 7 vge of transfection-derived DHBV/S1 with which 10 4 (1,000:1) or 10 5 (1,000:10) vge of transfection-derived wt DHBV had been admixed. Viremia was monitored by qPCR using variant-specific and wt-DHBV-specific primers as described in the legend to Fig. 5. (B) Newly emerged DHBV/S1 variants can coexist with or even outcompete wt DHBV when inoculated at 1,000-fold excess. DHBV/S1-L5A and DHBV/S1-L5T remained detectable at 2-to 3-log-lower titers than wt DHBV; in two animals coinoculated with DHBV/S1-V2 and wt DHBV exclusively, the variant was detectable. (C) DHBV/S1-V2 remains detectable upon coinoculation with higher proportions of wt DHBV. The animals were inoculated with 10 7 vge of DHBV/S2 plus the amount of wt DHBV generating the indicated ratios.
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on November 3, 2017 by guest http://jvi.asm.org/ serum samples taken 6 weeks p.i. revealed in all cases the exclusive presence of the new variants (data not shown).
To compare the fitnesses of the three new Dε/S1 variants to each other, we coinoculated three ducks each simultaneously with all three variants at a 1:1:1 ratio (0.66 ϫ 10 7 vge each). All three animals (no. 22/19 to 22/21) became viremic (not shown); 6 weeks p.i., in all of them, DHBV/S1-V2 was the dominant virus, as revealed by direct sequencing, supporting that DHBV/ S1-V2 was the fittest of the new variants.
To address whether DHBV/S1-V2 was able to compete with wt DHBV when inoculated at a lesser excess than in the initial experiments, we admixed to 10 7 vge of DHBV/S1-V2 increasing amounts of wt DHBV (10 4 , 10 5 , and 10 6 vge). Two of the three animals in each group showed detectable viremia (Fig.  7C) . Consistent with the previous data, one animal in the 1,000:1 group contained exclusively DHBV/S1-V2 (no. 24/1); the other (24/2) showed coinfection with wt DHBV at about a one-log-higher titer. Coexistence was also observed in one animal from the 1,000:10 group (no. 24/6), though wt-DHBV titers exceeded those of the variant by about 3 logs; in the second animal, a relatively low-titer (10 7 vge/ml) infection with only wt DHBV was detectable. In the two virus-positive animals from the 1,000:100 group, wt DHBV quickly reached high titers (10 9 vge/ml), yet the variant remained detectable in both ducks at low levels (ϳ10 6 vge/ml) until the end of the experiment at day 42 p.i.
These data confirmed the fitness gain of variant DHBV/ S1-V2 compared to the other variants, including DHBV/Hε; however, even DHBV/S1-V2 was outperformed by authentic wt DHBV unless inoculated in 1,000-fold excess.
Finally, to address whether one of the two new mutations in V2 contributed more to the increased fitness of DHBV/S1-V2, we introduced each mutation individually into the original DHBV/S1 genome, resulting in variants DHBV/S1-2584 and DHBV/S1-2620. Then, four ducks were each inoculated with mixtures of the two transfection-derived virions at ratios of 1:1 (10 7 ϩ 10 7 vge/inoculum) or with either virus at a 10-fold excess (10 7 vge of one virus plus 10 6 vge of the other). In most animals from the 1:1 group, mixed sequences were detected; in all from the 10:1 group, the virus given in excess dominated (data not shown). From these limited data, it appeared that neither of the two mutations was substantially more beneficial in vivo than the other.
Selection of variants DHBV/S1-L5T and DHBV/S1-L5A in vivo correlates with increased priming and replication competence in vitro. The in vivo data did not reveal which of the multiple functions of the Dε sequence (Fig. 2B) were responsible for the fitness gain. We therefore investigated the impact of the newly emerged mutations on parameters that can be measured in vitro. One option was that replacement of the fortuitous T2591g mutation at the loop 5 position in variants S1-L5T and S1-L5A and possibly one or both mutations in Dε/S1-V2 had a direct impact on productive interaction with P protein. When used as in vitro priming templates, all three new variants indeed gave approximately 2-fold-stronger signals than the original Dε/S1; mean values Ϯ SD from three independent experiments are indicated at the bottom of Fig. 8B . Though interexperiment variation did not allow exact statements, the trend was that the single replacements at position 2591 within the loop (Fig. 8A) provided a stronger enhancement than the two V2 mutations. It should be noted that the A2620G mutation of V2 was present in the template RNA, yet it is located downstream of the stem-loop structure ( Fig. 2A) , where it might have little impact on this assay.
If nucleotide position 2591 provided a particularly errorprone copying template, one might have expected that variants containing a C residue here would have been found in vivo, contrary to what was observed. We therefore extended our in ). The sum of rcDNA plus dsL-DNA signals was quantitated by phosphorimaging, and mean values Ϯ SD are given at the bottom; n ϭ 5 for original DHBV/S1 (ori), S1-L5A, S1-L5T, and S1-V2; n ϭ 3 for S1-V2-2584 and S1-V2-2620. (F) Lack of drastic impact on pet activity. Polyadenylated RNAs from cytoplasmic extracts of the same transfection experiment shown in panel E were analyzed by Northern blotting. The Northern experiment was performed only once. However, despite variation in total signal strength between RNA samples, no massive differences in the ratios of pgRNA to sgRNA were seen. Total RNAs before isolation of the polyadenylated species are shown in Fig. S7 in the supplemental material.
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vitro analyses to Dε RNAs containing all four possible nucleotides at the L5 position, both in the context of Dε/S1 (Fig. 8C ) and wt Dε (Fig. 8D) . As before, priming signals about 2-fold stronger than those obtained with the original Dε/S1 were obtained with variants Dε/S1-L5U and Dε/S1-L5A but not with Dε/S1-L5C. Similar though not identical results were obtained with the corresponding wt Dε RNAs. The original sequence (L5U) and the L5G variant performed best, whereas signals were about 5-fold reduced with the L5A and L5C RNAs. The different performances of L5A and L5G in Dε/S1 versus results for wt Dε imply that the differing sequence contexts in the upper stem affect the optimal sequence and structure of the conserved loop. Together, the data are consistent with the S1-L5A and S1-L5T mutations reflecting in vivo selection of DHBV/S1 toward higher replication initiation competence.
Next, we analyzed formation of replicative intermediates by the new variant genomes in transfected LMH cells (Fig. 8E) . As before, the original DHBV/S1 displayed an about 2-foldreduced replication capacity, whereas for all new variants, the mean DNA signal intensities (from 3 to 5 experiments) were higher if not wt-like. The relatively low DNA signals for variant DHBV/S1-V2-2584 in the particular experiment shown in Fig.  8E correlated with smaller amounts of total viral RNA (see Fig. S7 in the supplemental material); the significance of this observation remains to be determined.
No massive effect of D mutations on pet activity. The pet element overlaps completely with Dε (Fig. 2B) ; deletion of the sequence 2562 to 2619 reduced pgRNA to undetectable levels, whereas sgRNA levels increased (26) ; pet counteracts premature transcription termination mediated by the downstream net element (encompassed in the sequence 1 to 720) (10), but the molecular mechanism is unclear. To detect a potential influence of the Dε mutations on the relative ratios of pgRNA to sgRNA, cytoplasmic RNAs from transfected LMH cells were analyzed by Northern blotting. In total RNA, pgRNA levels were not much different, except for the DHBV/S1-V2-2584 sample (see Fig. S6 in the supplemental material; also see above). Because comigrating rRNA partly obscured the sgRNA signals, polyadenylated RNAs were isolated from the total RNA and analyzed again (Fig. 8F) . Despite variation in absolute signal intensities, the ratios of pgRNA signals to sgRNA signals were not drastically different between samples. The same was observed when in vitro-circularized monomer genomes (10) were used for transfection (data not shown). Thus, the artificial mutations in Dε had no major impact on pet activity; however, minor effects are not excluded.
Restored DHBeAg production may contribute to enhanced in vivo fitness of DHBV/S1-V2. Mutations within Dε and including A2610G alter the preC ORF (Fig. 9A) . The Dε/S1 mutations leave the ORF open but cause four amino acid exchanges in the center of the precore region, including introduction of a positive charge (T22R) into an otherwise hydrophobic environment. For wt DHBV16, the neural network algorithm of the SignalP server (16) predicts the bond between T35 and I36 as the major cleavage site; the Dε/S1 changes strongly reduce the probability score for cleavage (Fig. 9A) . DHBV/S1-L5A is genotypically precore deficient, since the L5A mutation alters the TTG codon for L25 into a stop codon (TAG). The a2584T mutation in V2 produces an L23S exchange (instead of L23T in the other S1 derivatives), and the second V2 mutation, A2620G, generates a T35A replacement.
To reveal potential effects on DHBeAg production, we tested various sera from ducks that were provenly infected (all with viral loads of 10 8 to 10 9 vge/ml) with wt DHBV16, DHBV/ S1, DHBV/S1-L5T, DHBV/S1-V2, and DHBV/Hε by immunoprecipitation and subsequent Western blotting (Fig. 9B) ; sera from three noninfected ducks and from a DHBV/S1-L5A-infected animal (no. 22/12) served as negative controls. DHBeAg from DHBV16 typically appears as two bands (51) with apparent molecular masses of about 27 kDa (nonglycosylated p27) and 30 kDa (glycosylated gp30).
Corresponding signals were seen in all three wt-DHBV16-positive sera but in none of the noninfected sera. Strong signals were also observed for the DHBV/Hε-positive serum, indicating that the preC sequence derived from HHBV could functionally replace the DHBV preC sequence, in accord with HHBV producing a similar eAg (46) and consistent with a high score in the SignalP prediction. Faint bands were also seen in the DHBV/S1-L5T serum; however, the doublet was shifted upwards, suggesting inefficient restoration of DHBeAg secretion, perhaps by processing at a different site. No signals were detectable in the genotypically negative DHBV/S1-L5A sample or in the original DHBV/S1 serum, demonstrating that this FIG. 9 . Mutations in DHBV/S1-V2 cause reversion to a DHBeAgpositive phenotype. (A) Alignment of preC amino acid sequences in the indicated variants. Identical amino acids are denoted by dots. The double backslash denotes the signal peptidase cleavage site predicted by the neural network algorithm implemented in SignalP; the C score is an indicator for the probability that the sequence acts as a signal peptide and is cleaved at the predicted site (16) . (B) Differential production of DHBeAg. Sera from the indicated animals were subjected to immunoprecipitation with a polyclonal antiserum recognizing DHBcAg and DHBeAg, followed by chemilumiscent detection using AP-conjugated anti-DHBc antibody 2B9-4F8. The reference DHBeAg was partially purified from culture medium of long-term induced and then rerepressed Dstet5 cells (20) , where viral transcription occurs primarily from cccDNA; recDHBc refers to wt DHBc recombinantly produced in Escherichia coli (39) . The faint signals in serum from the DHBV/S1-L5T-infected animal (arrows) may indicate inefficient and possibly aberrant DHBeAg processing. All virus-positive sera had titers of 10 8 to 10 9 vge/ml. Key to individual animals: wt DHBV16, no. 12/15, 22/24, and 24/17; DHBV/S1, no. 12/1; DHBV/S1-L5A, no. 22/12; DHBV/S1-L5T, no. 22/13; DHBV/S1-V2, no. 22/21; DHBV/Hε, no. 12/14.
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virus is phenotypically DHBeAg negative. In contrast, the DHBV/S1-V2 serum gave wt-DHBV16-like signals of only slightly reduced intensity. Notably, the unique T35A exchange strongly increases the probability score for cleavage between amino acids 35 and 36 (Fig. 9A) . Restoration of efficient DHBeAg secretion may therefore contribute to increased in vivo fitness of the DHBV/S1-V2 virus.
DISCUSSION
This is the first systematic in vivo analysis of the biological consequences of multiple nucleotide exchanges in the sequence encoding the RNA encapsidation signal of a hepadnavirus. Despite intrinsic interanimal variability, several generalizable conclusions can be drawn. First, our data revealed an unexpectedly high tolerance of all proposed functions of the Dε sequence toward multiple mutations; however, the single most important feature was the ability of a given Dε sequence to provide an RNA element for efficient productive interaction with P protein, thus shedding more light on the mechanism underlying this crucial interaction. Second, given their formation by error-prone copying processes, the variant genomes displayed a surprisingly high genetic stability, with practical implications for the design of future in vivo evolution experiments. Not least, the data in sum are compatible with the upper stem sequence in Dε providing an evolutionary playground for the virus to optimize biological fitness.
Tolerance of multiple D sequence functions toward multiple mutations. Several of the investigated viruses established chronic infection in vivo, directly demonstrating that various combinations of multiple mutations are compatible with all vital functions encoded in the Dε sequence. Where this was not seen, there was already a strict correlation with a strongly reduced (DHBV/S5) or abolished (DHBV/S2) replication capacity in transfected cells, consistent with very low in vitro priming activity (25) . Intriguingly, though, DHBV/S2 generated many more capsids (Fig. 3B ) from smaller amounts of pgRNA than any other construct (Fig. 3C) ; this may be of practical relevance whenever large amounts of DHBV core protein are required. While the exact mechanism remains to be determined, one factor certainly is that DHBV/S2 capsids did not contain detectable amounts of packaged pgRNA (Fig. 3D) ; hence all pgRNA molecules remain principally available to the translation machinery.
The second variant that failed to infect ducks was DHBV/S5. We cannot exclude that this was due to the specific genetic and/or immunological background of the three inoculated birds, but all other viruses inoculated into ducks from the same batch established infection (Fig. 4) . It is likely, then, that the lack of in vivo infectivity of DHBV/S5 is an intrinsic feature of the modified Dε sequence. DHBV/S5 replicated in transfected LMH cells (Fig. 3) and was infectious for PDH (Fig. 4 ), yet at at least 5-fold-lower levels than wt DHBV. All other virus variants displayed at most 2-fold-reduced replication levels in LMH cells (Fig. 3A) , and all established chronic in vivo infections ( Fig. 5 and 6A ). This suggests that a threshold replication rate of between 20% and 50% of that of wt DHBV is required to overcome in vivo host defenses that contain the spread of infection (28, 57, 65) . Since we did not find direct evidence for a major impact of the mutations on any other function of the Dε sequence, save on expression of DHBeAg (see below), the single most important contribution by a given Dε sequence to reproductive success probably comes from its ability to provide a suitable RNA template for productive interaction with P protein.
However, this does not imply that other functions are irrelevant in vivo. Very few of the mutations investigated are located directly within a proposed cis element (though this would not exclude an impact on function); for instance, the A2620G mutation in DHBV/S1-V2 is the only one that directly affects the proposed base pairing of region A to region B (34), yet only by changing a single A-U pair to a G-U pair within a stretch of about 50 nucleotides (nt) (not shown).
Perhaps more importantly, in cell culture various mutations within cis elements had gradual rather than massive effects, uncovered only by thorough quantitative assessment (21, 33, 34, 44) . The drastic impact of the pet element on pgRNA accumulation was discovered using large deletions (26) . None of the point mutations in Dε investigated here had a similar influence (Fig. 8F ), yet we would not have detected minor effects. This also holds for a potential interaction between the left half of Dε and the proposed DHBV element (54); however, the lack of a substantial replication defect seen in our variants is in line with the lacking phenotype of complementary mutations within the proposed sequence (35) . In sum, there is ample opportunity for mutations in the upper Dε stem to cause subtle disadvantages on multiple levels which synergistically make wt DHBV a better virus, as suggested by its ability to outcompete each of the variants in mixed infections.
Relative fitness as the most reliable way to compare biological performance of DHBV variants. In particular, DHBV/Hε displayed wt-DHBV-like infection characteristics in several ducks (Fig. 5A) , with maximum viremia titers reached already at day 7 p.i.; uncovering potential differences during the earlier phase by taking more-frequent blood samples at shorter intervals was not attempted for ethical reasons. Taken at face value, this would suggest that DHBV/Hε was as biologically fit as wt DHBV, but this did not hold up in direct competition. Relative fitness normalizes the fitness of a genotype to that of the fittest genotype, commonly the wild-type virus, which is assigned a relative fitness (w) of 1 (43) ; importantly, it also compensates for interanimal variation. Since neither DHBV/Hε nor any other variant was able to compete with wt DHBV when inoculated in equal amounts, all variants had a (w) value of Ͻ1. However, varying the input ratios allowed us to detect gradual relative fitness differences between individual variants and thus to unambiguously demonstrate adaptation in the case of DHBV/S1 (see below).
When inoculated in only 10-fold excess over wt DHBV, DHBV/Hε could not be detected at all; at 100-and 1,000-fold excess, it coexisted with wt DHBV in some animals but at 4-to 5-log-lower titers (Fig. 5B) . Stabilization of the ratio of the two viruses in the sera after a few weeks, also seen in other mixed infections, is consistent with the low dynamic state of infection reached when the available replication space, i.e., newly infectible hepatocytes, becomes limiting (64). The circulating viruses will then largely reflect the distribution of cccDNA molecules established by each virus during the early spreading phase. Further variation is limited by superinfection exclusion (60), the long half-life of cccDNA (35 to 57 days) (3, 48) , and low hepatocyte turnover (27 to 63 days) (37, 64) . Changes in distribution later in infection, not analyzed here, appear to be confined to upcoming changes in selection pressure and replication space (36) , e.g., if a variant is cytopathic (32) or if cells harboring the virus become a target for the immune system (63) . This likely also applies to human HBV (18) , particularly upon administration of antiviral drugs (66) .
For DHBV/S1, assessing its relative fitness proved to be the method of choice to confirm the fitness gain experienced by its descendants, DHBV/S1-L5T, DHBV/S1-L5A, and DHBV/S1-V2. The parental DHBV/S1 virus remained undetectable even if given at 1,000-fold excess over wt DHBV (Fig. 7A) , while the reverse was true for two animals coinoculated with DHBV/S1-V2; in the third, it coexisted with wt virus at about 1-log-lower titers (Fig. 7BC and) . Such coexistence was also seen at higher proportions of wt DHBV and in mixed infections involving DHBV/S1-L5A and DHBV/S1-L5T (Fig. 7B) . The adaptive nature of the new mutations was corroborated by the ability of all three DHBV/S1 descendants to outcompete a 10-fold excess of their ancestor.
However, even the adapted variants had a lower relative fitness than wt DHBV. A simple calculation shows how even small differences in the replication rate can have massive effects in vivo. The doubling time for DHBV-infected hepatocytes in ducklings has been estimated to be ϳ16 h (29) . Ten doublings would lead to an ϳ1,000-fold increase within 7 days and 20 doublings to a one-million-fold increase within 14 days, sufficient to spread from initially 10 4 infected hepatocytes throughout the liver (29) . A 2-fold-reduced replication rate lowers these increases to 32-fold and 1,000-fold, respectively, and a 5-fold-slower virus would take 70 days to reach the entire liver, leaving the host ample time to mount an effective antiviral response. The latter scenario likely applies to DHBV/S5 Other variants with less reduced replication in transfected cells (Fig. 3A) established in vivo infection but they were still efficiently replaced by wt DHBV; this is overall in line with previous reports on mixed infections with single-site variants having one-half to two-thirds the reproductive capacity of wt DHBV (63, 64) . However, wt-DHBV enrichment was more pronounced in our experiments, and even DHBV/S1-V2, which exerted no measurable replication deficiency in transfected cells (Fig. 8E) , required a 1,000-fold excess in the inoculum to outcompete wt DHBV. We assume that these quantitative differences relate to the multiple versus single mutations present in our viruses, which effectively prevent complete reversion to the wt sequence and concomitantly increase the probability of multiple factors affecting in vivo fitness (see above).
Why is adaptation of DHBV/S1 restricted to a few specific mutations in the modified D sequence, while DHBV/H does not seem to evolve at all? For DHBV/Hε, we did not detect accumulation of specific new mutations during repeated in vivo passages, and for DHBV/S1, the same four mutations emerged in separate ducks yet remained stable thereafter. This may appear surprising given that progeny rcDNA formation involves two error-prone copying processes, i.e., transcription of pgRNA by host RNA polymerase II, with an estimated error rate of around 10 Ϫ5 per site (41) , and reverse transcription of pgRNA by the viral polymerase (involving synthesis of two new DNA strands). Comparability of many published "mutation rates" suffers from different experimental setups and experimental imperfections (49) and the promiscuous use of different definitions of the term; useful distinctions are between the error rate of a polymerase, the mutation rate which accounts for additional mutations introduced by other events, and the substitution rate, which refers to those mutations that become fixed in the progeny, a complex product of mutation rate, generation time, population size, and fitness (15) . The most reliable estimates for the substitution rate in DHBV are derived from reversion of a cytopathic variant to noncytopathic descendants, and with (0.8 to 4.5) ϫ 10 Ϫ5 errors per genome synthesized (or one error per every 7 to 42 new genomes [47] ), they are in a range similar to those for HIV-1 (2). Assuming one error per 10 genomes synthesized and an equal probability for a mutation to occur at any of the 3,000 genome positions, about 90,000 new genomes should suffice to replace, with 95% probability, one nucleotide at one specific position by any of the other three nucleotides; replacement by one specific nucleotide at that site would require 3-fold more new genomes. Amplification rates in the range of 10 5 are easily reached upon low-titer in vivo inoculation; obviously, however, the chances for generating progeny genomes containing specific mutations at two or more defined sites become very slim. We thus ascribe the seeming discrepancy to the genetic stability observed for DHB/Hε and DHBV/S1 to two factors, namely, that any detectably accumulating new variant must have a substantially higher fitness than its parent and that such gain must be realized with one or few mutations. In this view, DHBV/Hε is sufficiently fit to have a head start over most single-mutation descendants such that many more generations would be required for a fitter mutant to emerge to detectable levels; in contrast, the L5G mutation in S1 causes a significant replication disadvantage that can easily be improved upon by one (S1-L5T or S1-L5A) or two (S1-V2) mutations within the modified Dε sequence. Any further descendants would face a situation analogous to that of descendants of DHBV/Hε. This view is in line with other recent in vivo evolution studies, where fitness typically rose rapidly and then plateaued (43) .
A low in vivo substitution rate in the absence of selective pressure has previously been observed for wt DHBV (47) , and no dominant mutations emerged in chimpanzees inoculated with clonal HBV (4). This suggests that although many mutations are generated, only a few make it into progeny ("purifying selection"), as is typical for viruses with small compact genomes (15) . However, the potential for mutation allows the virus to quickly respond to changes in extrinsic selection pressure, as is obvious from the inevitable emergence of resistant HBV variants under therapy with nucleos(t)ide analogs (66) .
Implications for the design of further in vivo evolution experiments with DHBV. Our data suggest important criteria for the design of in vivo evolution experiments with DHBV, schematically outlined in Fig. 10A . Obviously, the starting virus must be able to establish infection in vivo (unlike DHBV/S2 and DHBV/S5), which requires a threshold replication rate. Second, the starting virus should have intermediate relative fitness such that new, fitter variants have a chance to prevail. Third, the underlying mutation(s) in the starting virus must allow for a substantial fitness gain by few mutations. Unlike the loop L5G mutation in DHBV/S1, the upper stem mutations apparently did not meet this requirement. Similar data were obtained with a chimeric DHBV (Du-He4) that carries an VOL. 85, 2011 IN VIVO ANALYSIS OF DHBV ENCAPSIDATION SIGNAL VARIANTS 9311
on November 3, 2017 by guest http://jvi.asm.org/ about 70-amino-acid HHBV PreS segment in its large envelope protein; although HHBV does not infect ducks, the chimera did (13) . In accord with the high fitness of the parental Du-He4 virus and a low probability for improving functionality of the chimeric envelope protein by single mutations, new variants emerged only slowly. After three passages, an only partial enrichment of mutants bearing two amino acid changes at the borders of the HHBV segment was seen (K. Dallmeier and M. Nassal, unpublished data). Practically, in vivo SELEX procedures (14) may be more broadly applicable because mutational diversity, confined to the region of interest, is preestablished in vitro and the available replication space is not narrowed by an excess of an already relatively fit parental virus. Does DHBeAg increase in vivo fitness of DHBV/S1-V2? The increased fitness of DHBV/S1-V2 correlated with restoration of a DHBeAg-positive phenotype (Fig. 9B) , suggesting that expression of secreted DHBeAg (or the corresponding precore precursor) promoted efficient establishment of infection. Similarly, precore-negative HBV variants commonly arise only late during chronicity (12, 18) , and in ducks coinoculated with wt DHBV and a precore-negative single-site variant, the wt virus was strongly enriched in the early phase (63) . However, the variant also had a partial replication defect; hence, how much DHBeAg production contributed to the higher fitness of wt DHBV early in infection remains unclear. Analogously, the mutations in DHBV/S1-V2 simultaneously increased replication competence over that of the parental virus (Fig. 8) . Without further data, we consider it most likely that the increased fitness of DHBV/S1-V2 is the combined result of both factors and their easy generation by only two mutations.
Implications for the mechanism of the P-D interaction. The viability of several viruses containing multiple different substitutions in the upper stem of Dε directly shows that the altered nucleotides are not essential for formation of a priming-active P-ε complex, either during the initial recognition event or for establishing the rearranged, template-active conformation (Fig. 1B) . Hence, it is unlikely that they make any relevant direct interactions with P protein, and their impact on the RNA itself seems confined to preventing stable nonproductive structures by their low base-pairing potential (9, 25) . More surprisingly, all variants supported formation of the correct DNA primer; otherwise, no proper minus-strand DNA and rcDNA could have been formed (Fig. 1A) . Thus, P protein still recognizes the authentic initiation site on the mutant templates. This strongly suggests that the principal, and possibly separate, recognition elements within Dε (Fig. 10B) are the bulge and its underlying two or three base pairs (50) and the apical loop (9, 19, 27, 56) . The mere presence of the intervening upper stem sequences could still help proper positioning of P protein by confining the distance between the bulge and the loop (a hypothesis currently being tested by modifying the length of the upper stem; M. Gajer and M. Nassal, unpublished data). Alternatively, by not being essential for but contributing to this and other functions of the Dε sequence, they may enable the virus to sample multiple sequences for optimal fitness. Notably, the region encoding the right upper half-stem is one of the rare spots where the genomes of DHBV16 and an Eastern isolate from Australia (GenBank accession no. AJ006350) differ at five consecutive positions (see Fig. S1 in the supplemental material). Based on monoinfection data, the two viruses appeared to be similarly infectious for Pekin ducks (58) . Comparing their relative fitnesses in mixed infections, as was done here with the artificial DHBV variants, should provide a feasible test for this hypothesis. The graph schematically depicts important constraints for applying in vivo evolution methods to DHBV; it does not imply quantitative relationships, except that wt DHBV has a relative fitness of 1.0 and a replication capacity of 100%. Key features are that a specific starting variant have a threshold replication capacity to be able to establish in vivo infection; its relative fitness, however, should not be too high so as to allow outgrowth of fitter mutants. Only within this window can new variants be expected to accumulate to detectable levels within a reasonable time period. Further constraints are the potential of the starting sequence to allow substantial fitness gains by a few mutations and the limited replication space in the duck liver (affected by the size of the inoculum and growth rate of the starting virus). (B) Implications for productive interaction between P protein and Dε RNA. Formation of initiation complexes with site-specific (encircled C residue) priming activity by various multiply mutated Dε sequences indicates that the corresponding nucleotides (labeled with NЈs) are not involved in crucial contacts with P protein. The rapid counterselection against the L5G mutation in DHBV/S1 in vivo plus previous in vitro data imply that specificity of the P-Dε interaction resides instead in the bulge and the apical loop and that both act as independent elements (symbolized by the octagons). Our in vivo data further exclude a critical dependence of other functions on the authentic upper stem sequence. The still unmatched performance of wt DHBV in mixed infections versus the natural sequence variability in this region (see Fig. S1 in the supplemental material) may be reconciled if the upper stem sequence provided an evolutionary playground for fine-tuning viral fitness.
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